Viking Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VKTX and other ETFs, options, and stocks.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
CEOBrian Lian
CEOBrian Lian
Employees27
Employees27
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees27
Employees27
VKTX Key Statistics
Market cap6.92B
Market cap6.92B
Price-Earnings ratio-70.69
Price-Earnings ratio-70.69
Dividend yield—
Dividend yield—
Average volume2.38M
Average volume2.38M
High today$65.75
High today$65.75
Low today$62.65
Low today$62.65
Open price$64.54
Open price$64.54
Volume616.02K
Volume616.02K
52 Week high$99.41
52 Week high$99.41
52 Week low$8.28
52 Week low$8.28
VKTX News
Seeking Alpha 19h
Viking Therapeutics: An Oral Weight Loss Drug With More Data Ahead - Seeking AlphaXavier Lorenzo/iStock via Getty Images Viking Therapeutics, Inc. (NASDAQ:VKTX) is developing VK2735 for obesity, among other drugs in its pipeline, and has rep...
Benzinga 24h
Market Whales and Their Recent Bets on VKTX Options - Viking Therapeutics - BenzingaLoading... Loading... Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics VKTX. And retail traders should know. We noti...
Yahoo Finance 2d
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 - Yahoo FinanceConference Call Scheduled for Wednesday, April 24 at 4:30 p.m. Eastern Time SAN DIEGO, April 17, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NAS...
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%